Eric Thomas Schmidt, Chief Financial Officer at Allogene Therapeutics, Inc. (ALLO), sold 22,938 shares at $7.63 ($175K) on 2022-03-15, disclosed to the SEC on 2022-03-17.
Seasonal sale ($175k) by Chief Financial Officer — this insider has traded ALLO in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.63 | 11,469 | $88K | 50.0% |
| 2 | $7.63 | 11,469 | $88K | 50.0% |
| Total | $7.63 avg | 22,938 | $175K | 100% |
| Filing → |
| ALLO | SELL | 2020-11-18 | $644K | — | Filing → |
| ALLO | SELL | 2020-10-16 | $1.2M | — | Filing → |
| ALLO | SELL | 2020-09-22 | $944K | — | Filing → |